NO954952D0 - Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac - Google Patents
Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenacInfo
- Publication number
- NO954952D0 NO954952D0 NO954952A NO954952A NO954952D0 NO 954952 D0 NO954952 D0 NO 954952D0 NO 954952 A NO954952 A NO 954952A NO 954952 A NO954952 A NO 954952A NO 954952 D0 NO954952 D0 NO 954952D0
- Authority
- NO
- Norway
- Prior art keywords
- dosage form
- pct
- solid dosage
- oral solid
- form containing
- Prior art date
Links
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title abstract 3
- 229960001259 diclofenac Drugs 0.000 title abstract 3
- 239000008184 oral solid dosage form Substances 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 150000003839 salts Chemical class 0.000 abstract 2
- 229920000858 Cyclodextrin Polymers 0.000 abstract 1
- 238000007907 direct compression Methods 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- GDSRMADSINPKSL-HSEONFRVSA-N gamma-cyclodextrin Chemical compound OC[C@H]([C@H]([C@@H]([C@H]1O)O)O[C@H]2O[C@@H]([C@@H](O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O[C@H]3O[C@H](CO)[C@H]([C@@H]([C@H]3O)O)O3)[C@H](O)[C@H]2O)CO)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@@H]3O[C@@H]1CO GDSRMADSINPKSL-HSEONFRVSA-N 0.000 abstract 1
- 229940080345 gamma-cyclodextrin Drugs 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medical Informatics (AREA)
- Rheumatology (AREA)
- Biophysics (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Immunology (AREA)
- Pain & Pain Management (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH171193 | 1993-06-08 | ||
PCT/EP1994/001662 WO1994028936A1 (en) | 1993-06-08 | 1994-05-24 | Process for the preparation of an oral solid dosage form containing diclofenac |
Publications (3)
Publication Number | Publication Date |
---|---|
NO954952L NO954952L (no) | 1995-12-06 |
NO954952D0 true NO954952D0 (no) | 1995-12-06 |
NO315844B1 NO315844B1 (no) | 2003-11-03 |
Family
ID=4216820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19954952A NO315844B1 (no) | 1993-06-08 | 1995-12-06 | Farmasöytisk produkt, inklusjonsforbindelse, samt fremgangsmåte for fremstilling av en nevnte inklusjonsforbindelse |
Country Status (14)
Country | Link |
---|---|
US (1) | US5702724A (no) |
EP (1) | EP0701449B1 (no) |
JP (2) | JPH08511009A (no) |
AT (1) | ATE246515T1 (no) |
AU (1) | AU6971294A (no) |
CA (1) | CA2163111C (no) |
DE (1) | DE69433012T2 (no) |
DK (1) | DK0701449T3 (no) |
ES (1) | ES2204918T3 (no) |
FI (1) | FI116039B (no) |
NO (1) | NO315844B1 (no) |
NZ (1) | NZ267417A (no) |
PT (1) | PT701449E (no) |
WO (1) | WO1994028936A1 (no) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU4353996A (en) * | 1994-12-14 | 1996-07-03 | Bioglan Ireland (R & D) Limited | Pharmaceutical tablet formulations for direct compression |
HUP9600758A2 (en) * | 1996-03-27 | 1998-03-02 | Cyclolab Ciklodextrin Kutato F | Diclofenac composition of diminished gastrointestinal irritation and enhanced biological resorption |
US6720005B1 (en) * | 2000-07-07 | 2004-04-13 | The State Of Oregon Acting By And Through The State Board Of Higher Education On Behalf Of Oregon State University | Coated, platform-generating tablet |
AR030630A1 (es) * | 2000-09-11 | 2003-08-27 | Novartis Ag | Composiciones farmaceuticas |
AR036312A1 (es) * | 2001-08-31 | 2004-08-25 | Novartis Ag | Composicion farmaceutica |
JP2005298338A (ja) * | 2002-02-27 | 2005-10-27 | Eisai Co Ltd | 速崩壊性圧縮成形製剤 |
EP1492520A1 (en) * | 2002-03-07 | 2005-01-05 | Novartis AG | Pharmaceutical compositions |
US20040241234A1 (en) * | 2003-06-02 | 2004-12-02 | Alpharma, Inc. | Controlled release press-coated formulations of water-soluble active agents |
DE102004060914A1 (de) * | 2004-12-17 | 2006-07-06 | Bioghurt Biogarde Gmbh & Co. Kg | Verwendung von Liponsäure-haltigen Cyclodextrin-Komplexen |
EP1707217A1 (en) * | 2004-12-17 | 2006-10-04 | Wacker Chemie AG | Process for preparing an alpha lipoic acid/cyclodextrin complex and product prepared |
KR20090010953A (ko) * | 2006-03-28 | 2009-01-30 | 자블린 파머슈티칼스 인코포레이티드 | 저 복용량의 비-스테로이드성 항염증성 약물 및 베타-사이클로덱스트린 제형 |
CN102846585A (zh) | 2006-03-28 | 2013-01-02 | 杰佛林制药公司 | 低剂量的双氯芬酸和β-环糊精的制剂 |
WO2011001228A1 (en) * | 2008-08-14 | 2011-01-06 | Shasun Chemicals And Drugs Limited | Aryl alkyl carboxylic acid salts, process for preparation and dosage forms |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5959632A (ja) * | 1982-09-28 | 1984-04-05 | Teikoku Chem Ind Corp Ltd | 徐放性組成物 |
JPS5984821A (ja) * | 1982-11-04 | 1984-05-16 | Teikoku Chem Ind Corp Ltd | 徐溶化組成物 |
FR2660195B1 (fr) * | 1990-03-28 | 1994-10-07 | Crinex Sa Laboratoires | Composition pharmaceutique a macher, antiinflammatoire et/ou analgesique. |
IT1243342B (it) * | 1990-07-13 | 1994-06-10 | Farcon Ag | Composizioni farmaceutiche orali liquide ad attivita' antiinfiammatoria |
EP0487774B1 (en) * | 1990-11-29 | 1994-10-26 | Wei Ming Pharmaceutical Mfg. Co. Ltd. | A direct tabletting auxiliary |
US5231089A (en) * | 1991-12-02 | 1993-07-27 | University Of Florida | Method of improving oral bioavailability of carbamazepine |
-
1994
- 1994-05-24 JP JP7501246A patent/JPH08511009A/ja active Pending
- 1994-05-24 CA CA2163111A patent/CA2163111C/en not_active Expired - Lifetime
- 1994-05-24 DE DE69433012T patent/DE69433012T2/de not_active Expired - Lifetime
- 1994-05-24 AT AT94918361T patent/ATE246515T1/de active
- 1994-05-24 PT PT94918361T patent/PT701449E/pt unknown
- 1994-05-24 EP EP94918361A patent/EP0701449B1/en not_active Expired - Lifetime
- 1994-05-24 DK DK94918361T patent/DK0701449T3/da active
- 1994-05-24 US US08/556,979 patent/US5702724A/en not_active Expired - Lifetime
- 1994-05-24 WO PCT/EP1994/001662 patent/WO1994028936A1/en active IP Right Grant
- 1994-05-24 AU AU69712/94A patent/AU6971294A/en not_active Abandoned
- 1994-05-24 ES ES94918361T patent/ES2204918T3/es not_active Expired - Lifetime
- 1994-05-24 NZ NZ267417A patent/NZ267417A/en not_active IP Right Cessation
-
1995
- 1995-12-04 FI FI955837A patent/FI116039B/fi not_active IP Right Cessation
- 1995-12-06 NO NO19954952A patent/NO315844B1/no not_active IP Right Cessation
-
2005
- 2005-05-31 JP JP2005160207A patent/JP2005247874A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CA2163111A1 (en) | 1994-12-22 |
ATE246515T1 (de) | 2003-08-15 |
DE69433012T2 (de) | 2004-06-09 |
US5702724A (en) | 1997-12-30 |
NO954952L (no) | 1995-12-06 |
EP0701449B1 (en) | 2003-08-06 |
NO315844B1 (no) | 2003-11-03 |
DK0701449T3 (da) | 2003-11-10 |
CA2163111C (en) | 2010-10-26 |
WO1994028936A1 (en) | 1994-12-22 |
FI955837A (fi) | 1995-12-04 |
AU6971294A (en) | 1995-01-03 |
NZ267417A (en) | 1997-02-24 |
JPH08511009A (ja) | 1996-11-19 |
FI955837A0 (fi) | 1995-12-04 |
EP0701449A1 (en) | 1996-03-20 |
FI116039B (fi) | 2005-09-15 |
ES2204918T3 (es) | 2004-05-01 |
JP2005247874A (ja) | 2005-09-15 |
DE69433012D1 (de) | 2003-09-11 |
PT701449E (pt) | 2003-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL99759A (en) | Mono-fluorinated derivatives of n-propargyl-1-aminoindan, their preparation and pharmaceutical compositions containing them | |
ES2157993T3 (es) | Benzoilguanidinas, su preparacion y su uso en medicamentos. | |
NO954952D0 (no) | Fremgangsmåte for fremstilling av en oral fast-stoff doseringsform som inneholder diklofenac | |
CA2047744A1 (en) | Method for the synthesis of huperzine a and analogs thereof and compounds useful therein | |
FI972434A0 (fi) | Lamotrigiiniä sisältävä farmaseuttinen koostumus | |
GR890100833A (en) | Process for the preparation of a compound with gastric inhibitopy effect | |
DK0866711T3 (da) | Anvendelse af 6-methyl-5-oxo-3-thiomorpholinylcarbonyl-L-histidyl-L-prolinamid til fremstilling af et farmaceutisk præparat til modvirkning af sövnapnö | |
NZ332545A (no) | ||
HU9500175D0 (en) | Pharmacologically active alpha-[tertiary-aminomethyl]-benzenemethanol derivatives | |
AU675281B2 (en) | Application of riluzole as a radiorestorer | |
NO964921D0 (no) | Mellomprodukt for fremstilling av farmasöytisk aktiv forbindelse | |
HUT68015A (en) | New compound leustroducsin h, its preparation and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MK1K | Patent expired |